The National Diabetes Audit (NDA) continues to provide a comprehensive view of Diabetes Care in England and Wales and measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards, in England and Wales. This national report presents the key findings and recommendations on care processes and treatment target achievement rates from 2015-2016 in all age groups in England and Wales along with information on offers and attendance for structured education places. This year, for the first time information is reported on the number of people with diabetes who also have a learning disability and completion of care processes and treatment target achievement. A separate national report presents the key findings and recommendations; The Learning Disability - Supplementary Information report has also been developed as a power point presentation. As with last year's publication the main report contains information on the national key findings and recommendations and has also been developed as a power point presentation, along with slides highlighting the national findings there is also space to allow the incorporation of locally produced slides using the tables and charts from the interactive spreadsheets. We hope that users will find this beneficial to help disseminate the results of the audit locally. Supplementary data for England and Wales are contained in the excel spreadsheets. There are 6 excel spreadsheets; two spreadsheets contains the tables and charts in the national report and learning disability report along with some supplementary national figures, a further spreadsheet provides all 8 care process completion and all 3 treatment target achievement for CCGs/LHBs by age group. There are also 3 interactive excel spreadsheets which allow users to select the CCG/GP practice (England only), Local Health Board (Wales only) or Secondary Care Service (England only) of choice, information for the chosen site is then displayed in tables and charts. Please note that the interactive excel spreadsheets are large files (approximately 12MB) and may take some time to open. This report was updated on 09/02/17. The following amendments have been made to the report: The CCG/GP spreadsheet was updated as some of the CCGs/general practices were not available in the interactive aspect. We have also added a reference table for practice codes and names. All the data for care processes and treatment targets was correct in the supporting data tables. The spreadsheet report for Wales and LHBs has been amended. A practice wrongly appeared in a LHB, this practice has now been assigned to the correct LHB which has changed the results for LHB 7A2 and 7A3. The specialist service spreadsheet has been updated as the interactive aspect was not working for all hospitals. This does not change the results for specialist services. Both the CCG/GP and LHB spreadsheets have been updated for structured education offered and attendance. This has changed the results for individual CCGs/Practices and LHBs but not the national results. We have updated the methodology documentation for structured education to explain more fully how we have analysed and reported on the structured education data for the 2015-16 audit report. We have also added a link, which can be found below in resources, to our interactive dashboard for the 2015-16 report. This dashboard provides CCGs, LHBs and GPs (England only) with an alternative way to view their data for completion of all 8 care process and achievement of all 3 treatment targets as well their data on registrations by age, sex, deprivation and ethnicity.

The National Diabetes Insulin Pump Audit is part of the National Diabetes Audit (NDA).

The National Diabetes Insulin Pump Audit collects information on the number and characteristics of people with Type 1 diabetes using an insulin pump, the reasons for going on an insulin pump and the outcomes achieved since starting on the pump.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Diabetes Insulin Pump Audit data for 2016-17 is available at England and Wales, Local Health Board (LHB) and Specialist Diabetes Service level for:

• Participation
• Patient demographics
• Prevalence
• Care process completion
• Treatment targets
• Diabetes characteristics

Using and interpreting the data

Data from the National Diabetes Insulin Pump Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Local Health Boards and Specialist Diabetes Services are identified by organisation code.

What does the data cover?

The audit looks at the following areas:

• Reason for starting on an insulin pump
• Care processes
• Treatment targets
• Structured Education

What period does the data cover?

This data covers the top level findings from the 2016-17 National Diabetes Insulin Pump Audit for the period 1 January 2016 to 31 March 2017. This National Report was published on 14 June 2018.

The National Diabetes Audit (NDA) provides a comprehensive view of diabetes care in England and Wales and measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Diabetes Audit data for 2016-17 is available at England and Wales, Clinical Commissioning Group (CCG), Local Health Board (LHB), English GP practice and Specialist Diabetes Service level for:

• Participation
• Patient demographics
• Diabetes characteristics
• Structured Education offers

These data do not list individual patient information nor do they contain any patient identifiable data.

Using and interpreting the data

Data from the National Diabetes Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. GP practices and CCGs/LHBs are identified by organisation code.

What does the data cover?

The audit looks at the following areas:

• Care processes
• Treatment targets
• Structured Education

What period does the data cover?

This data covers the top level findings from the 2016-17 National Diabetes Audit for the period 1 January 2016 to 31 March 2017. This National Report was published on 10 November 2017.

What information is being made available? Trust, service, and clinical commissioning group (CCG) audit participation and data completeness for the key fields Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Diabetes Foot Care Audit (NDFA) is a continuous audit of diabetic foot disease in England and Wales. The audit enables all diabetes foot care services to measure their performance against NICE clinical guidelines and peer units, and to monitor adverse outcomes for people with diabetes who develop diabetic foot disease. Measures about the process of care given to patients Information about care outcomes and treatment. These data do not list individual patient information nor do they contain any patient identifiable data. Using and interpreting the data Data from the National Diabetes Foot Care Audit should not be looked at in isolation when assessing standards of care. Accessing the data The data are being made available on the data.gov website. Each year a data file from the National Diabetes Foot Care Audit will be made available in CSV format. Trusts, CCGs and Networks are identified by name and their national code. Foot care services are identified by name and locally derived code. What does the data cover? The audit looks at the following areas: Structures: are the nationally recommended care structures in place for the management of diabetic foot disease? Processes: does the treatment of active diabetic foot disease comply with nationally recommended guidance?

The National Pregnancy in Diabetes (NPID) audit is part of the National Diabetes Audit (NDA) programme and is commissioned by the Healthcare Quality Improvement Partnership (HQIP) as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP). The NDA is managed by the NHS Digital in partnership with Diabetes UK and is supported by Public Health England (PHE). The audit is a measurement system to support improvement in the quality of care for women with diabetes who are pregnant or planning pregnancy and seeks to address the three key questions: - Were women with diabetes adequately prepared for pregnancy? - Were adverse maternal outcomes during pregnancy minimised? - Were adverse fetal/infant outcomes minimised? This report includes data on women with diabetes with completed pregnancies between 1 January 2016 and 31 December 2016 and where the data was submitted to the audit by 10 February 2017. In 2016, 3,304 pregnancies in 3,297 women with diabetes were recorded in 172 antenatal diabetes services.

The National Diabetes Inpatient Audit (NaDIA) is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and delivered by NHS Digital, working with Diabetes UK. The National Diabetes Inpatient Audit is a snapshot audit of diabetes inpatient care. Between 26-30 September 2016, the National Diabetes Inpatient Audit was conducted in hospitals across England and Wales, collecting data on characteristics of the hospital including staffing structures, patient clinical data and patient experience information. The audit looks at the following areas: • Did diabetes management minimise the risk of avoidable complications? • Did harm result from the inpatient stay? • Was patient experience of the inpatient stay favourable? • Has the quality of care and patient feedback changed? The Annual Report provides a summary of the 2016 audit findings for England and Wales, and where possible compares to the 2011, 2012, 2013 and 2015 audit findings. There was no audit collection or report in 2014, so 2014 data is not available. The audit is supported by the Hospital Level Analysis, which provides results at individual site level. This publication has changed in terms of structure from previous years in that the main report is now available in PowerPoint and PDF format. Each individual section/chapter of the report is also available as separate standalone PDF/PowerPoint documents in the Short Reports zip folder below.

The National Diabetes Foot Care Audit (NDFA) is a continuous audit of diabetic foot disease in England and Wales. The audit enables all diabetes foot care services to measure their performance against NICE clinical guidelines and peer units, and to monitor adverse outcomes for people with diabetes who develop diabetic foot disease. All organisations which provide a diabetic foot ulcer treatment service are eligible for inclusion in the audit. The audit reports on the following: Structures: are the nationally recommended care structures in place for the management of diabetic foot disease? Processes: does the treatment of active diabetic foot disease comply with nationally recommended guidance? Outcomes: are the outcomes of diabetic foot disease optimised? The NDFA is part of the National Diabetes Audit programme (NDA). The NDFA is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and delivered by NHS Digital, working with Diabetes UK. As well as a national report, which provides information about foot care across England and Wales, separate local reports are also available. The comparative local reports show data at service (specialist foot care teams), provider (Trust/Local Health Board), commissioner (Clinical Commissioning Group) and network (Strategic Clinical Network) level.

The National Diabetes Transition Audit (NDTA) is a joint enterprise between the National Diabetes Audit (NDA) and the National Paediatric Diabetes Audit (NPDA) measuring the care of young people with diabetes during the transition from paediatric diabetes services to adult diabetes services.

This is the second published report for the NDTA and contains linked data from the NPDA and NDA for the audit period 2011-12 to 2016-17. The report focuses on young people with Type 1 diabetes.

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Diabetes Transition Audit data for 2011-17 is available at England and Wales, Clinical Commissioning Group (CCG), Local Health Board (LHB) and Specialist Diabetes Service level for:

• Participation
• Patient demographics
• Prevalence
• Diabetes characteristics

Using and interpreting the data

Data from the National Diabetes Insulin Pump Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Local Health Boards and Specialist Diabetes Services are identified by name and organisation code.

What does the data cover?

The audit looks at the following areas:

• Care processes
• Treatment targets
• Structured Education
• Paediatric Services
• Adult Services
• Service Moves

What period does the data cover?

This data covers the top level findings from the 2011-17 National Diabetes Transition Audit for the period 1 April 2011 to 31 March 2017. This National Report was published on 10 January 2019.

The National Diabetes Inpatient Audit (NaDIA) measures the quality of diabetes care provided to people with diabetes while they are admitted to hospital whatever the cause, and aims to support quality improvement. Data is collected and submitted by hospital staff in England and Wales. The NaDIA audit is part of the National Diabetes Audit (NDA) portfolio within the National Clinical Audit and Patient Outcomes Programme (NCAPOP), commissioned by the Healthcare Quality Improvement Partnership (HQIP). The audit sets out to measure the quality of diabetes care provided to people with diabetes while they are admitted to hospital, by answering the following questions: Did diabetes management minimise the risk of avoidable complications? Did harm result from the inpatient stay? Was patient experience of the inpatient stay favourable? Has the quality of care and patient feedback changed since NaDIA 2010, 2011, 2012, 2013, 2015 and 2016?

The National Pregnancy in Diabetes Audit (NPID) is a workstream of the National Diabetes Audit (NDA) and is managed by NHS Digital under an agreement with the Healthcare Quality Improvement Partnership (HQIP) on behalf of NHS England and the Welsh Government.

The NDA is delivered by NHS Digital, in partnership with Diabetes UK and the National Cardiovascular Intelligence Network (part of Public Health England).

Making clinical audit data transparent

In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme.

What information is being made available?

National Pregnancy in Diabetes Audit data for 2018 is available at England and Wales, Region and Provider level for:

• Participation
• Patient demographics
• Quality of care during pregnancy

Using and interpreting the data

Data from the National Pregnancy in Diabetes Audit should not be looked at in isolation when assessing standards of care.

Accessing the data

The data are being made available on the data.gov website. Local Health Boards and Specialist Diabetes Services are identified by organisation code.

What does the data cover?

The audit looks to address the following three key questions:

• Were women with diabetes adequately prepared for pregnancy?
• Were appropriate steps taken during pregnancy to minimise adverse outcomes to the mother?
• Were adverse neonatal outcomes minimised?

What period does the data cover?

This data covers the findings from the National Pregnancy in Diabetes Audit for the period 1 January 2016 to 31 December 2018. This National Report was published on 10 October 2019.

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The National Diabetes Foot Care Audit (NDFA) is a continuous audit of diabetic foot disease in England and Wales. The audit enables all diabetes foot care services to measure their performance against NICE clinical guidelines and peer units, and to monitor adverse outcomes for people with diabetes who develop diabetic foot disease. What information is being made available?  Trust, service, and clinical commissioning group (CCG) audit participation and data completeness for the key fields Measures about the process of care given to patients  Information about care outcomes and treatment. These data do not list individual patient information nor do they contain any patient identifiable data. Using and interpreting the data Data from the National Diabetes Foot Care Audit should not be looked at in isolation when assessing standards of care. Accessing the data The data are being made available on the data.gov website. Each year a data file from the National Diabetes Foot Care Audit will be made available in CSV format. Trusts, CCGs and Networks are identified by name and their national code. Foot care services are identified by name and locally derived code. What does the data cover? The audit looks at the following areas: Structures: are the nationally recommended care structures in place for the management of diabetic foot disease? Processes: does the treatment of active diabetic foot disease comply with nationally recommended guidance? Outcomes: are the outcomes of diabetic foot disease optimised? What period does the data cover? This data covers patients first seen with a diabetic foot ulcer by a specialist foot team between 14 July 2014 and 8 April 2016. This National Report was published on 8 March 2017.

This set of files contains public data used to validate the grocery data. All references to the original sources are provided below.CHILD OBESITYPeriodically, the English National Health Service (NHS) publishes statistics about various aspects of the health and habits of people living in England, including obesity. The NHS National Child Measurement (NCMP) measures the height and weight of children in Reception class (aged 4 to 5) and year 6 (aged 10 to 11), to assess overweight and obesity levels in children within primary schools. The program is carried out every year in England and statistics are produced at the level of Local Authority (that corresponds to Boroughs in London). We report the data for the school year 2015-2016 (file: child_obesity_london_borough_2015-2016.csv). For the school year 2013-2014, statistics in London are also available at ward-level (file: child_obesity_london_ward_2013-2014.csv)The files are comma-separated and contain the following fields: area_id: the id of the boroughnumber_reception_measured: number of children in reception year measurednumber_y6_measured: number of children in reception year measuredprevalence_overweight_reception: the prevalence (percentage) of overweight children in reception year prevalence_overweight_y6: the prevalence (percentage) of overweight children in year 6prevalence_obese_reception: the prevalence (percentage) of obese children in reception yearprevalence_obese_y6: the prevalence (percentage) of obese children in year 6ADULT OBESITYThe Active People Survey (APS) was a survey used to measure the number of adults taking part in sport across England and included two questions about the height and weight of participants. We report the results of the APS for the year 2012. Prevalence of underweight, healthy weight, overweight, and obese people at borough level are provided in the file london_obesity_borough_2012.csv.The file is comma-separated and contains the following fields: area_id: the id of the boroughnumber_measured: number of people who participated in the surveyprevalence_healthy_weight: the prevalence (percentage) of healthy-weight peopleprevalence_overweight: the prevalence (percentage) of overweight peopleprevalence_obese: the prevalence (percentage) of obese peopleBARIATRIC HOSPITALIZATIONThe NHS records and publishes an annual compendium report about the number of hospital admissions attributable to obesity or bariatric surgery (i.e., weight loss surgery used as a treatment for people who are very obese), and the number of prescription items provided in primary care for the treatment of obesity. The NHS provides both raw counts at the Local Authority level and numbers normalized by population living in those areas. In the file obesity_hospitalization_borough_2016.csv, we report the statistics for the year 2015 (measurements made between Jan 2015 and March 2016).The file is comma-separated and contains the following fields:area_id: the id of the boroughtotal_hospitalizations: total number of obesity-related hospitalizationstotal_bariatric: total number of hospitalizations for bariatric surgeryprevalence_hospitalizations: prevalence (percentage) of obesity-related hospitalizations prevalence_bariatric: prevalence (percentage) of bariatric surgery hospitalizations DIABETESThrough the Quality and Outcomes Framework, NHS Digital publishes annually the number of people aged 17+ on a register for diabetes at each GP practice in England. NHS also publishes the number of people living in a census area who are registered to any of the GP in England. Based on these two sources, an estimate is produced about the prevalence of diabetes in each area. The data (file diabetes_estimates_osward_2016.csv) was collected in 2016 at LSOA-level and published at ward-level.The file is comma-separated and contains the following fields:area_id: the id of the wardgp_patients: total number of GP patients gp_patients_diabetes: total number of GP patients with a diabetes diagnosisestimated_diabetes_prevalence: prevalence (percentage) of diabetesAREA MAPPINGMapping of Greater London postcodes into larger geographical aggregations. The file is comma-separated and contains the following fields:pcd: postcodelat: latitudelong: longitudeoa11: output arealsoa11: lower super output areamsoa11: medium super output areaosward: wardoslaua: borough

Making clinical audit data transparent In his transparency and open data letter to Cabinet Ministers on 7 July 2011, the Prime Minister made a commitment to make clinical audit data available from the national audits within the National Clinical Audit and Patient Outcomes Programme. The information available from this webpage comes from the National Diabetes Inpatient Audit. The National Diabetes Inpatient Audit is a snapshot audit of diabetes inpatient care. In September 2015 the National Diabetes Inpatient Audit was conducted in hospitals across England and Wales, collecting data on characteristics of the hospital including staffing structures, patient clinical data and patient experience information. What information is being made available?  Audit participation and data completeness for the key fields  Measures about the process of care given to patients  Information about care outcomes and treatment. These data do not list individual patient information nor do they contain any patient identifiable data. Using and interpreting the data Data from the National Diabetes Inpatient Audit should not be looked at in isolation when assessing standards of care. Accessing the data The data are being made available on the data.gov website. Each year files of data from the National Diabetes Inpatient Audit will be made available in CSV format. Hospitals are identified by name and their national code. What does the data cover? The audit looks at the following areas: • Did diabetes management minimise the risk of avoidable complications? • Did harm result from the inpatient stay? • Was patient experience of the inpatient stay favourable? • Has the quality of care and patient feedback changed? What period does the data cover? This data covers patients surveyed on a date between 21 and 25 September 2015. This publication was produced in two parts: the comparative hospital-level analysis was published on 08 March 2016 and the National Report was published on 23 June 2016.

The excel file contains unit, regional and national level data obtained from the 2016-17 National Paediatric Diabetes Audit.

Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2016 and the 31 March 2017.

Data are included for the seven key health checks:

• Glycated Haemoglobin A1c (HbA1c)

• Body Mass Index (BMI)

• Thyroid

• Blood pressure

• Urinary albumin

• Foot examination

• Eye screening.

Data on other health checks include:

• Psychological support

• Structured Education

• Cholesterol

• Screening for autoimmune disease (coeliac and thyroid disease)

Data on outcomes of care include:

• HbA1c target measurements

• Small vessel (microvascular) disease

• Large vessel (macrovascular) disease

• Autoimmune disease (coeliac and thyroid disease)

The data were first published in July 2018 alongside the National Paediatric Diabetes Audit Report 2016-17. Data suppressed due to small numbers (<5).

For further information and details on the audit please refer to:

• Supporting documents (see below): link to National Paediatric Diabetes Audit Report 2016-17 and Sustainability and Transformation Partnership (STP) level data

• NPDA results online: http://npda-results.rcpch.ac.uk/default.aspx

• The RCPCH website: https://www.rcpch.ac.uk/work-we-do/quality-improvement-patient-safety/national-paediatrics-diabetes-audit

National Diabetes Insulin Pump Audit jest częścią National Diabetes Audit (NDA).

National Diabetes Insulin Pump Audit gromadzi informacje na temat liczby i cech osób z cukrzycą typu 1 za pomocą pompy insulinowej, powodów uruchomienia pompy insulinowej oraz wyników osiągniętych od momentu uruchomienia pompy.

Wykonywanie danych z audytu klinicznego przezroczyste

W piśmie dotyczącym przejrzystości i otwartych danych skierowanym do ministrów gabinetu w dniu 7 lipca 2011 r. premier zobowiązał się do udostępnienia danych z audytu klinicznego z audytów krajowych w ramach krajowego programu audytu klinicznego i wyników pacjentów.

Jakie informacje są udostępniane?_

Dane z audytu pompy insulinowej na poziomie National Diabetes Insulin Pump za lata 2016-17 są dostępne w Anglii i Walii, Lokalnej Radzie Zdrowia (LHB) i Specjalistycznej Służbie Cukrzycy dla:

• Uczestnictwo
• Demografia pacjentów
• Rozpowszechnienie
• Zakończenie procesu opieki
• Cele leczenia
• Charakterystyka cukrzycy

Wykorzystanie i interpretacja danych

Dane z National Diabetes Insulin Pump Audit nie powinny być analizowane w izolacji przy ocenie standardów opieki.

Dostęp do danych Dane są udostępniane na stronie data.gov. Lokalne rady zdrowia i specjalistyczne służby cukrzycowe są identyfikowane według kodu organizacji.

Co obejmują dane?_

W ramach audytu przeanalizowano następujące obszary:

• Powód uruchomienia pompy insulinowej
• Procesy opieki * Cele leczenia

• Ustrukturyzowana edukacja

  Jaki okres obejmuje dane?_

Dane te obejmują ustalenia najwyższego poziomu z krajowego audytu pompy insulinowej w latach 2016–2017 za okres od dnia 1 stycznia 2016 r. do dnia 31 marca 2017 r. Niniejsze sprawozdanie krajowe zostało opublikowane w dniu 14 czerwca 2018 r.

The excel file contains unit, regional and national level data obtained from the 2014-15 National Paediatric Diabetes Audit.

Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2014 and the 31 March 2015.

Data are included for the seven key health checks:

• Glycated Haemoglobin A1c (HbA1c)

• Body Mass Index (BMI)

• Cholesterol

• Blood pressure

• Urinary albumin

• Foot examination

• Eye screening

Data on other health checks include:

• Psychological support

• Structured Education

• Screening for autoimmune disease (coeliac and thyroid disease)

Data on outcomes of care include:

• HbA1c target measurements

• Small vessel (microvascular) disease

• Large vessel (macrovascular) disease

• Autoimmune disease (coeliac and thyroid disease)

The data were first published in May 2016 alongside the National Paediatric Diabetes Audit Report 2014-15. Data suppressed due to small numbers (<5).

NB: Due to data corruption of ethnicity data submitted, this 2014-15 report does not include ethnicity data for patients in individual units for comparison across units regionally and nationally. Ethnicity has therefore not been used as a variable in the HbA1c case-mix adjustments.

For further information and details on the audit please refer to:

• Supporting documents (see below): link to National Paediatric Diabetes Audit Report 2014-15

• NPDA results online: http://npda-results.rcpch.ac.uk/default.aspx

• The RCPCH website: https://www.rcpch.ac.uk/work-we-do/quality-improvement-patient-safety/national-paediatrics-diabetes-audit

The excel file contains unit, regional and national level data obtained from the 2015-16 National Paediatric Diabetes Audit. Specifically, it includes information on patient characteristics, completion of health checks and outcomes achieved (as recommended by the National Institute for Clinical Excellence) for infants, children and young people with type 1 diabetes, under the age of 25, who attended paediatric diabetes units in England and Wales between 1 April 2015 and the 31 March 2016. Data are included for the seven key health checks: • Glycated Haemoglobin A1c (HbA1c) • Body Mass Index (BMI) • Thyroid • Blood pressure • Urinary albumin • Foot examination • Eye screening Data on other health checks include: • Psychological support • Structured Education • Cholesterol • Screening for autoimmune disease (coeliac and thyroid disease) Data on outcomes of care include: • HbA1c target measurements • Small vessel (microvascular) disease • Large vessel (macrovascular) disease • Autoimmune disease (coeliac and thyroid disease) The data were first published in February 2017 alongside the National Paediatric Diabetes Audit Report 2015-16. Data suppressed due to small numbers (<5). For further information and details on the audit please refer to: • Supporting documents (see below): link to National Paediatric Diabetes Audit Report 2015-16 • NPDA results online: http://npda-results.rcpch.ac.uk/default.aspx • The RCPCH website: https://www.rcpch.ac.uk/work-we-do/quality-improvement-patient-safety/national-paediatrics-diabetes-audit

Le National Diabetes Insulin Pump Audit fait partie du National Diabetes Audit (NDA).

L'audit national de la pompe à insuline pour le diabète recueille des informations sur le nombre et les caractéristiques des personnes atteintes de diabète de type 1 utilisant une pompe à insuline, les raisons d'utiliser une pompe à insuline et les résultats obtenus depuis le démarrage de la pompe.

Rendre les données d'audit clinique transparentes

Dans sa lettre de transparence et de données ouvertes adressée aux ministres le 7 juillet 2011, le Premier ministre s'est engagé à mettre à disposition les données d'audit clinique issues des audits nationaux dans le cadre du programme national d'audit clinique et de résultats pour les patients.

Quelles informations sont mises à disposition? Les données du National Diabetes Insulin Pump Audit pour 2016-2017 sont disponibles au niveau de l'Angleterre et du Pays de Galles, du Local Health Board (LHB) et du Specialist Diabetes Service pour:

• Participation
• Démographie des patients
• Prévalence
• Achèvement du processus de soins
• Objectifs de traitement
• Caractéristiques du diabète Utilisation et interprétation des données

Les données de l'audit national de la pompe à insuline pour le diabète ne doivent pas être examinées isolément lors de l'évaluation des normes de soins.

Accès aux données

Les données sont mises à disposition sur le site data.gov.Les conseils locaux de la santé et les services spécialisés en diabète sont identifiés par code d'organisation.

Qu'est-ce que les données couvrent?
L'audit porte sur les domaines suivants:

• Raison du démarrage d'une pompe à insuline
  • Processus de soins
• Objectifs de traitement
• Éducation structurée

Quelle est la période couverte par les données? Ces données couvrent les principales conclusions de l'audit national 2016-2017 de la pompe à insuline pour le diabète pour la période allant du 1er janvier 2016 au 31 mars 2017. Le présent rapport national a été publié le 14 juin 2018.Le National Diabetes Insulin Pump Audit fait partie du National Diabetes Audit (NDA).

L'audit national de la pompe à insuline pour le diabète recueille des informations sur le nombre et les caractéristiques des personnes atteintes de diabète de type 1 utilisant une pompe à insuline, les raisons d'utiliser une pompe à insuline et les résultats obtenus depuis le démarrage de la pompe.

Rendre les données d'audit clinique transparentes

Dans sa lettre de transparence et de données ouvertes adressée aux ministres le 7 juillet 2011, le Premier ministre s'est engagé à mettre à disposition les données d'audit clinique issues des audits nationaux dans le cadre du programme national d'audit clinique et de résultats pour les patients.

Quelles informations sont mises à disposition?

Les données du National Diabetes Insulin Pump Audit pour 2016-2017 sont disponibles au niveau de l'Angleterre et du Pays de Galles, du Local Health Board (LHB) et du Specialist Diabetes Service pour:

• Participation
• Démographie des patients
• Prévalence
• Achèvement du processus de soins
• Objectifs de traitement
  • Caractéristiques du diabète

Utilisation et interprétation des données

Les données de l'audit national de la pompe à insuline pour le diabète ne doivent pas être examinées isolément lors de l'évaluation des normes de soins.

Accès aux données

Les données sont mises à disposition sur le site data.gov. Les conseils locaux de la santé et les services spécialisés en diabète sont identifiés par code d'organisation.

Qu'est-ce que les données couvrent?

L'audit porte sur les domaines suivants:

• Raison du démarrage d'une pompe à insuline

• Processus de soins

• Objectifs de traitement

• Éducation structurée

Quelle est la période couverte par les données?

Ces données couvrent les principales conclusions de l'audit national 2016-2017 de la pompe à insuline pour le diabète pour la période allant du 1er janvier 2016 au 31 mars 2017. Le présent rapport national a été publié le 14 juin 2018.

Das National Diabetes Audit (NDA) bietet einen umfassenden Überblick über die Diabetesversorgung in England und Wales und misst die Wirksamkeit der Diabetesversorgung anhand der NICE Clinical Guidelines und der NICE-Qualitätsstandards.

Klinische Auditdaten transparent machen

In seinem Transparenz- und Open-Data-Brief an die Kabinettsminister vom 7. Juli 2011 verpflichtete sich der Premierminister, klinische Auditdaten aus den nationalen Audits im Rahmen des National Clinical Audit and Patient Outcomes Programme zur Verfügung zu stellen. Welche Informationen werden zur Verfügung gestellt?

National Diabetes Audit Daten für 2016-17 ist verfügbar bei England und Wales, Clinical Commissioning Group (CCG), Local Health Board (LHB), Englisch GP Praxis und Specialist Diabetes Service Ebene für:

• Teilnahme
• Patientendemografie
• Diabetes-Eigenschaften

• Strukturierte Bildungsangebote

  Diese Daten enthalten keine individuellen Patienteninformationen und auch keine patientenidentifizierbaren Daten.

Verwendung und Interpretation der Daten

Daten aus dem National Diabetes Audit sollten bei der Bewertung von Pflegestandards nicht isoliert betrachtet werden.

Zugriff auf die Daten

Die Daten werden auf der Website data.gov zur Verfügung gestellt. GP-Praktiken und CCGs / LHBs werden durch den Organisationscode identifiziert.

Was umfassen die Daten?

Die Prüfung befasst sich mit folgenden Bereichen:

• Pflegeprozesse

• Behandlungsziele

• Strukturierte Bildung

Welchen Zeitraum decken die Daten ab?

Diese Daten decken die Top-Level-Ergebnisse aus dem National Diabetes Audit 2016-17 für den Zeitraum vom 1. Januar 2016 bis zum 31. März 2017 ab. Dieser Nationale Bericht wurde am 10. November 2017 veröffentlicht.

Nacionalinis diabeto auditas (NDA) pateikia išsamų diabeto priežiūros Anglijoje ir Velse vaizdą ir matuoja diabeto sveikatos priežiūros veiksmingumą prieš NICE klinikines gaires ir NICE kokybės standartus.

Klinikinio audito duomenų skaidrumo užtikrinimas

2011 m. liepos 7 d. Vyriausybės ministrams skirtame skaidrumo ir atvirųjų duomenų rašte Ministras Pirmininkas įsipareigojo pateikti klinikinio audito duomenis, gautus atlikus nacionalinius auditus pagal Nacionalinę klinikinio audito ir pacientų rezultatų programą.

Kokia informacija skelbiama?

Nacionalinio diabeto audito 2016–2017 m. duomenys yra prieinami Anglijoje ir Velse, Klinikinių tyrimų grupėje (CCG), Vietos sveikatos valdyboje (LHB), Anglijos bendrosios praktikos gydytojo praktikoje ir diabeto specialistų tarnybos lygmeniu:

• Dalyvavimas
• Pacientų demografija
• Diabeto charakteristikos
• Struktūrinis švietimas pasiūlymai

Šiuose duomenyse nėra nei atskirų pacientų informacijos, nei paciento tapatybės duomenų.

Duomenų naudojimas ir aiškinimas

Vertinant sveikatos priežiūros standartus, nacionalinio diabeto audito duomenys neturėtų būti vertinami atskirai.

Prieiga prie duomenų

Duomenys skelbiami data.gov svetainėje. Bendrosios praktikos gydytojai ir KCD / LHB identifikuojami pagal organizacijos kodą.

Ką apima šie duomenys?

Audito metu nagrinėjamos šios sritys:

• Priežiūros procesai

• Gydymo tikslai

• Struktūrinis švietimas

Kokį laikotarpį apima duomenys?

Šie duomenys apima aukščiausio lygio 2016–2017 m. nacionalinio diabeto audito išvadas dėl laikotarpio nuo 2016 m. sausio 1 d. iki 2017 m. kovo 31 d. Ši nacionalinė ataskaita paskelbta 2017 m. lapkričio 10 d.